Imagine living a life that is as active as you could wish. Would it involve walking, gardening, and traveling? Do you envision playing with your grandchildren, hosting holiday get-togethers, and enjoying time with loved ones? Well, you deserve that life—even if you struggle with knee osteoarthritis (OA) pain.
You aren’t alone—not by a long shot!
OA affects more than 32.5 million US adults, and the knee is frequently affected.1 While no treatment can completely stop OA, it is possible to slow the damage, reduce pain and improve joint function.2,3
Taking steps to manage knee OA
Treatment goals for knee OA often include decreasing symptoms, improving joint function, and maintaining quality of life.4 How to achieve your goals will depend on many factors, which your doctor will discuss with you to develop a treatment plan. Tip: Use the self-assessment tool to help prepare for talking with your doctor about your OA symptoms.
Keep in mind that treatment usually begins with noninvasive therapies, such as lifestyle changes and low-impact physical activity.4 Medication—from over-the-counter pain relievers to corticosteroids injections—also may help.
Hyaluronic acid (HA) therapy is another option to treat mild to moderate knee OA. Found naturally throughout the body, HA is a component of synovial fluid, a substance that lubricates healthy joints.
HA: Worth a closer look
HA therapy can provide strong knee OA pain relief that lasts longer than steroid injections, with fewer risks or side effects.5-7 Remarkably, repeated HA injections may even delay the need for knee replacement surgery.*1
A unique HA therapy, DUROLANE requires only one injection and one doctor’s visit, while providing up to 6 months of pain relief.8 DUROLANE is a non-addictive, non-opioid therapy that is covered by Medicare and many major Medicare Advantage plans.
Don't let knee OA hold you back
Take control of your knee OA journey. A good place to start is with the helpful resources—OA health information, product rebates, and more—at DUROLANE.com. Your doctor can also tell you more about DUROLANE and other OA treatment options that can help you get back to the active life you want!
Click here to learn about the causes of osteoarthritis, ways to stay active, and more.
*The study by Altman et al. 2015 does not contain data specific to DUROLANE
References:
1. Centers for Disease Control and Prevention. Osteoarthritis. Last reviewed June 12, 2023. https://www.cdc.gov/arthritis/types/osteoarthritis.htm
2. Altman R, Lim S, Steen RG, Dasa V. Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: evidence from a large U.S. health claims database. PLoS One. 2015;10(12):e0145776. doi:10.1371/journal.pone.0145776
3. McGrath AF, McGrath AM, Jessop ZM, et al. A comparison of intra-articular hyaluronic acid competitors in the treatment of mild to moderate knee osteoarthritis. J Arthritis. 2013:2(1);1000108. doi:10.4172/2167-7921.1000108
4. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoarthritis: Diagnosis, Treatment, and Steps to Take. Last reviewed September 2023. https://www.niams.nih.gov/health-topics/osteoarthritis/diagnosis-treatment-and-steps-to-take
5. Leighton R, Åkermark C, Therrien R, et al. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthritis Cartilage. 2014;22(1):17-25. doi:10.1016/j.joca.2013.10.009
6. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3-9.
7. McAlindon TE, LaValley MP, Harvey WF, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967-75. doi:10.1001/jama.2017.5283
8. Zhang H, Zhang K, Zhang X, et al. Comparison of two hyaluronic acid formulations for safety and efficacy (CHASE) study in knee osteoarthritis: a multicenter, randomized, double-blind, 26-week non-inferiority trial comparing Durolane to Artz. Arthritis Res Ther. 2015;17:51. doi:10.1186/s13075-015-0557-x
Summary of Indications for Use: DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen. Risks can include transient pain or swelling at the injection site.
See full prescribing information at www.DUROLANE.com.
DUROLANE, Bioventus, and the Bioventus logo are registered trademarks of Bioventus LLC.
© 2024 Bioventus LLC. SMK-005470A 04/24
Getty Images
